BeiGene (BGNE) Short Interest Ratio & Short Volume → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free BGNE Stock Alerts $160.56 -1.92 (-1.18%) (As of 05/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media BeiGene Short Interest DataCurrent Short Volume1,840,000 sharesPrevious Short Volume1,730,000 sharesChange Vs. Previous Month+6.36%Dollar Volume Sold Short$254.66 millionShort Interest Ratio / Days to Cover7.5Last Record DateApril 15, 2024Outstanding Shares95,640,000 sharesPercentage of Shares Shorted1.92%Today's Trading Volume111,912 sharesAverage Trading Volume252,932 sharesToday's Volume Vs. Average44% Short Selling BeiGene ? Sign up to receive the latest short interest report for BeiGene and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBGNE Short Interest Over TimeBGNE Days to Cover Over TimeBGNE Percentage of Float Shorted Over Time Ad InvestorPlaceThe Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.Go here now for this breaking story. BeiGene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,840,000 shares $254.66 million +6.4%N/A7.5 $138.40 3/31/20241,730,000 shares $270.55 million No ChangeN/A6.6 $156.39 3/15/20241,730,000 shares $294.10 million -10.4%N/A5.9 $170.00 2/29/20241,930,000 shares $319.70 million +10.3%N/A6.6 $165.65 2/15/20241,750,000 shares $255.62 million -15.9%N/A6.2 $146.07 1/31/20242,080,000 shares $308.32 million -2.4%N/A7.4 $148.23 Get the Latest News and Ratings for BGNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BeiGene and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,130,000 shares $373.20 million +16.4%N/A8.3 $175.21 12/31/20231,830,000 shares $330.06 million +20.4%N/A7.5 $180.36 12/15/20231,520,000 shares $278.27 million +26.7%N/A6.8 $183.07 11/30/20231,200,000 shares $224.33 million -18.9%N/A5.6 $186.94 11/15/20231,480,000 shares $290.88 million +23.3%N/A6.9 $196.54 10/31/20231,200,000 shares $223.54 million -28.6%N/A5.7 $186.28 10/15/20231,680,000 shares $300.37 million +1.2%N/A7.5 $178.79 9/30/20231,660,000 shares $298.58 million No ChangeN/A7.7 $179.87 9/15/20231,660,000 shares $332.53 million No ChangeN/A7.4 $200.32 8/31/20231,660,000 shares $344.53 million -4.1%N/A6.8 $207.55 8/15/20231,730,000 shares $350.71 million +7.5%N/A7.2 $202.72 7/31/20231,610,000 shares $344.89 million -10.1%N/A7 $214.22 7/15/20231,790,000 shares $351.43 million -2.7%N/A8.6 $196.33 6/30/20231,840,000 shares $328.07 million +1.1%N/A8.5 $178.30 6/15/20231,820,000 shares $365.89 million -1.1%N/A8.4 $201.04 5/31/20231,840,000 shares $406.51 million -2.7%N/A9.5 $220.93 5/15/20231,890,000 shares $454.07 million -9.1%N/A9.4 $240.25 4/30/20232,080,000 shares $530.32 million -4.6%N/A9.9 $254.96 4/15/20232,180,000 shares $575.52 million +1.4%N/A9.9 $264.00 3/31/20232,150,000 shares $463.39 million -1.4%N/A9 $215.53 3/15/20232,180,000 shares $514.37 million +7.9%N/A8.9 $235.95 2/28/20232,020,000 shares $453.75 million +4.1%N/A8 $224.63 2/15/20231,940,000 shares $463.18 million -0.5%N/A7.2 $238.75 1/31/20231,950,000 shares $499.20 million +1.6%N/A7.1 $256.00 1/15/20231,920,000 shares $519.67 million -6.3%N/A7.1 $270.66 12/30/20222,050,000 shares $450.88 million +2.0%N/A7.3 $219.94 12/15/20222,010,000 shares $417.92 million +2.0%N/A7.2 $207.92 11/30/20221,970,000 shares $377.47 million -4.8%N/A7.4 $191.61 11/15/20222,070,000 shares $429.96 million -3.7%N/A8.7 $207.71 10/31/20222,150,000 shares $363.11 million +7.5%N/A9.3 $168.89 10/15/20222,000,000 shares $311.68 million -12.7%N/A8.4 $155.84 9/30/20222,290,000 shares $308.74 million +13.9%N/A10.7 $134.82 9/15/20222,010,000 shares $322.87 million +3.1%N/A8.4 $160.63 8/31/20221,950,000 shares $334.74 million -7.1%N/A7.7 $171.66The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read BGNE Short Interest - Frequently Asked Questions What is BeiGene's current short interest? Short interest is the volume of BeiGene shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 1,840,000 shares of BGNE short. Learn More on BeiGene's current short interest. What is a good short interest ratio for BeiGene? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BGNE shares currently have a short interest ratio of 8.0. Learn More on BeiGene's short interest ratio. Which institutional investors are shorting BeiGene? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BeiGene: Concourse Financial Group Securities Inc., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is BeiGene's short interest increasing or decreasing? BeiGene saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,840,000 shares, an increase of 6.4% from the previous total of 1,730,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BeiGene's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to BeiGene: BioMarin Pharmaceutical Inc. (1.94%), Viatris Inc. (3.55%), Teva Pharmaceutical Industries Limited (1.04%), Karuna Therapeutics, Inc. (5.16%), Dr. Reddy's Laboratories Limited (0.45%), Sarepta Therapeutics, Inc. (5.15%), Alnylam Pharmaceuticals, Inc. (1.98%), Genmab A/S (0.40%), United Therapeutics Co. (9.96%), Catalent, Inc. (3.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short BeiGene stock? Short selling BGNE is an investing strategy that aims to generate trading profit from BeiGene as its price is falling. BGNE shares are trading down $1.92 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BeiGene? A short squeeze for BeiGene occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BGNE, which in turn drives the price of the stock up even further. How often is BeiGene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BGNE, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TEVA Short Interest BMRN Short Interest VTRS Short Interest SRPT Short Interest RDY Short Interest UTHR Short Interest GMAB Short Interest ALNY Short Interest CTLT Short Interest ROIV Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BGNE) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing